Acute effects of oestrogen on the guinea pig and humanIKrchannels and drug‐induced prolongation of cardiac repolarization
- 15 June 2008
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 586 (12) , 2961-2973
- https://doi.org/10.1113/jphysiol.2007.150367
Abstract
Female gender is a risk factor for drug‐induced arrhythmias associated with QT prolongation, which results mostly from blockade of thehuman ether‐a‐go‐go‐related gene(hERG) channel. Some clinical evidence suggests that oestrogen is a determinant of the gender‐differences in drug‐induced QT prolongation and baseline QTCintervals. Although the chronic effects of oestrogen have been studied, it remains unclear whether the gender differences are due entirely to transcriptional regulations through oestrogen receptors. We therefore investigated acute effects of the most bioactive oestrogen, 17β‐oestradiol (E2) at its physiological concentrations on cardiac repolarization and drug‐sensitivity of the hERG (IKr) channel in Langendorff‐perfused guinea pig hearts, patch‐clamped guinea pig cardiomyocytes and culture cells over‐expressing hERG. We found that physiological concentrations of E2 partially suppressedIKrin a receptor‐independent manner. E2‐induced modification of voltage‐dependence causes partial suppression of hERG currents. Mutagenesis studies showed that a common drug‐binding residue at the inner pore cavity was critical for the effects of E2 on the hERG channel. Furthermore, E2 enhanced both hERG suppression and QTCprolongation by its blocker, E4031. The lack of effects of testosterone at its physiological concentrations on both of hERG currents and E4031‐sensitivity of the hERG channel implicates the critical role of aromatic centroid present in E2 but not in testosterone. Our data indicate that E2 acutely affects the hERG channel gating and the E4031‐induced QTCprolongation, and may provide a novel mechanism for the higher susceptibility to drug‐induced arrhythmia in women.Keywords
This publication has 30 references indexed in Scilit:
- Recent advances in understanding sex differences in cardiac repolarizationProgress in Biophysics and Molecular Biology, 2007
- Influence of Menstrual Cycle on QT Interval DynamicsPacing and Clinical Electrophysiology, 2006
- Molecular Determinants of hERG Channel BlockMolecular Pharmacology, 2006
- Estrogen and Progestin Use and the QT Interval in Postmenopausal WomenAnnals of Noninvasive Electrocardiology, 2004
- Estrogen-induced Smooth Muscle Cell Growth Is Regulated by Tuberin and Associated with Altered Activation of Platelet-derived Growth Factor Receptor-β and ERK-1/2Journal of Biological Chemistry, 2004
- Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de PointesFundamental & Clinical Pharmacology, 2004
- K+ Channel Structure-Activity Relationships and Mechanisms of Drug-Induced QT ProlongationAnnual Review of Pharmacology and Toxicology, 2003
- Tea+-Sensitive Kcnq1 Constructs Reveal Pore-Independent Access to Kcne1 in Assembled IKs ChannelsThe Journal of general physiology, 2001
- Mutations of the S4‐S5 linker alter activation properties of HERG potassium channels expressed in Xenopus oocytesThe Journal of Physiology, 1999
- Female gender as a risk factor for torsades de pointes associated with cardiovascular drugsJAMA, 1993